These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3208210)

  • 41. The use of botulinum toxin in the medical management of benign essential blepharospasm.
    Perman KI; Baylis HI; Rosenbaum AL; Kirschen DG
    Ophthalmology; 1986 Jan; 93(1):1-3. PubMed ID: 3951806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Who needs botulinum toxin?
    Pittar G; Dunlop DB; Dunlop C
    Med J Aust; 1988 Sep; 149(5):232-3. PubMed ID: 3045506
    [No Abstract]   [Full Text] [Related]  

  • 44. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.
    Dutton JJ
    Surv Ophthalmol; 1996; 41(1):51-65. PubMed ID: 8827930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of dystonic blepharospasm and hemifacial spasm with botulinum toxin: preliminary studies].
    Martí MJ; Kulisevsky J; Tolosa E
    Med Clin (Barc); 1987 Sep; 89(8):321-3. PubMed ID: 3320608
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of blepharospasm, hemifacial spasm and strabismus with botulinum a toxin.
    Dai Z; Wang YC
    Chin Med J (Engl); 1992 Jun; 105(6):476-80. PubMed ID: 1451548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ophthalmologic use of botulinum A exotoxin.
    Carruthers JD
    Can J Ophthalmol; 1985 Jun; 20(4):135-41. PubMed ID: 4052862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin for the treatment of essential blepharospasm.
    Shore JW; Leone CR; O'Connor PS; Neuhaus RW; Arnold AC
    Ophthalmic Surg; 1986 Nov; 17(11):747-53. PubMed ID: 3808585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.
    Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA
    Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical doxorubicin chemomyectomy. An experimental treatment for benign essential blepharospasm and hemifacial spasm.
    Wirtschafter JD
    Ophthalmology; 1991 Mar; 98(3):357-66. PubMed ID: 2023757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of botulinum toxin type A for the treatment of facial spasm.
    Serrano LA
    Bol Asoc Med P R; 1993; 85(1-3):7-11. PubMed ID: 8060446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin A injection in the treatment of hemifacial spasm.
    Chen RS; Lu CS; Tsai CH
    Acta Neurol Scand; 1996 Sep; 94(3):207-11. PubMed ID: 8899054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Botulinum A toxin injection as a treatment for blepharospasm.
    Scott AB; Kennedy RA; Stubbs HA
    Arch Ophthalmol; 1985 Mar; 103(3):347-50. PubMed ID: 3977705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
    Bastola P; Chaudhary M; Agrawal JP; Shah DN
    Kathmandu Univ Med J (KUMJ); 2010; 8(31):305-10. PubMed ID: 22610735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hemifacial spasm treated with botulinum toxin].
    Jedynak CP; Palfi S; Vidailhet M; Kullmann B
    Rev Neurol (Paris); 1993; 149(3):202-6. PubMed ID: 8235213
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Botulinum toxin A in clinical medicine.
    Elston JS
    J Physiol (Paris); 1990; 84(4):285-9. PubMed ID: 2079665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term enhancement of botulinum toxin injections by upper-eyelid surgery in 14 patients with facial dyskinesias.
    Mauriello JA; Keswani R; Franklin M
    Arch Otolaryngol Head Neck Surg; 1999 Jun; 125(6):627-31. PubMed ID: 10367918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurological application of botulinum toxin.
    Kumar P; Crowley WJ
    Mo Med; 1989 Dec; 86(12):815-7. PubMed ID: 2695823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The management of blepharospasm and hemifacial spasm.
    Elston JS
    J Neurol; 1992 Jan; 239(1):5-8. PubMed ID: 1541971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of botulinum toxin therapy for essential blepharospasm.
    Engstrom PF; Arnoult JB; Mazow ML; Prager TC; Wilkins RB; Byrd WA; Hofmann RJ
    Ophthalmology; 1987 Aug; 94(8):971-5. PubMed ID: 3658374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.